Moreover, the miR-150-low/IGF2BP1-high expression was significantly associated with high tumor grade (P = 0.01), positive metastasis (P < 0.001) and recurrence (P < 0.001), and poor response to chemotherapy (P = 0.001) of patients with osteosarcomas (Table 1). Here, IGF2BP1 is linked to neoplasm.